ArticleBMC infectious diseases2015
Erysipelas, a large retrospective study of aetiology and clinical presentation.
Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.
- Pooled it
- Machine learning model to predict mortality in patients with skin and soft tissue infection in emergency department.Scandinavian journal of trauma, resuscitation and emergency medicine · 2025Article
- Milian's ear sign: A sign for facial erysipelas.Paediatrics & child health · 2025Article
- Atypical Erysipelas With Serohematic Bullae and Necrosis: A Delayed Diagnostic and Therapeutic Challenge.Cureus · 2025Article
- Primary and Recurrent Erysipelas-Epidemiological Patterns in a Single-Centre Retrospective Analysis.Journal of clinical medicine · 2025Article
- Superficial Mycoses: A Mapping Through Bibliometric Research.Mycopathologia · 2025Review
- Global research trends and hotspots in erysipelas: a bibliometric analysis from 2000 to 2024.Frontiers in medicine · 2025Article
- Characteristics and Antibiotic Treatment of Patients with Cellulitis in the Emergency Department.Antibiotics (Basel, Switzerland) · 2024Article
- Review
- Incidence of remote consultation on general practitioners' antibiotic prescriptions in 2021: a French observational study.BJGP open · 2024Article
- A sex-based analysis of complete blood count features during acute, untreated Lyme disease.Frontiers in medicine · 2024Article
- Clinical Impact ofAntibiotics (Basel, Switzerland) · 2023Review
- Review
- The bacterial pathogen and resistance spectrum in a dermatological inpatient ward: a six-year, retrospective, epidemiological study.GMS hygiene and infection control · 2022Article
- The Initial Stage of Neutrophilic Dermatosis of the Dorsal Hands: A Case Report and Discussion of Differential Diagnoses.The Journal of clinical and aesthetic dermatology · 2021Article
- Erysipelas Complicated with Acute Exudative Pericarditis.Medicina (Kaunas, Lithuania) · 2020Article
- 55-year old woman with erysipelas.Postepy dermatologii i alergologii · 2020Article
- Colonization of β-hemolytic streptococci in patients with erysipelas-a prospective study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019Article
- Factors associated with blood culture positivity in patients with complicated skin and skin structure infection-a population-based study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019Observational
- Comorbidities as Risk Factors for Acute and Recurrent Erysipelas.Open access Macedonian journal of medical sciences · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundErysipelas is a common and severe infection where the aetiology and optimal management is not well-studied. Here, we investigate the clinical features, bacteriological aetiology, and treatment of erysipelas.
methodsEpisodes of erysipelas in a seven-years period in our institution were studied retrospectively using a pre-specified protocol and is presented with descriptive and comparative statistics.
results1142 episodes of erysipelas were identified in 981 patients. Patients had a median age of 61 years, 59 % were male, a majority had underlying diseases or predisposing conditions, and the leg was most often affected. Wound cultures were taken in 343 episodes and 56 grew group A streptococci (GAS), 53 grew group G streptococci (GGS), 11 grew group C streptococci (GCS), and 153 grew Staphylococcus aureus. Blood cultures were drawn in 49 % of episodes and 50 cultures were positive with GGS as the most common finding (21 cultures) followed by GAS in 13, group B streptococci in 5, S. aureus in 4, and GCS in 3 cultures. In 45 % of episodes, patients received antibiotics with activity against S. aureus.
conclusionsGGS is the most common streptococcus isolated in erysipelas and the role of S. aureus in erysipelas remains elusive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.